Persistence of superficial basal cell carcinoma during pembrolizumab treatment for metastatic melanoma. Russo I, Filoni A, Alaibac M. Eur J Dermatol 2021 Feb 12. pii: ejd.2020.3958. doi: 10.1684/ejd.2020.3958.

Read + Share

Amedeo Smart

Independent Medical Education

Russo I, Filoni A, Alaibac M. Persistence of superficial basal cell carcinoma during pembrolizumab treatment for metastatic melanoma. Eur J Dermatol 2021 Feb 12. pii: ejd.2020.3958. doi: 10.1684/ejd.2020.3958.
PMID: 33586650